Walleye Capital LLC lifted its position in shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS – Get Rating) by 103.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 44,204 shares of the company’s stock after purchasing an additional 22,427 shares during the period. Walleye Capital LLC’s holdings in Stereotaxis were worth $81,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of STXS. Amalgamated Bank purchased a new stake in shares of Stereotaxis during the first quarter worth about $30,000. Wellington Shields & Co. LLC purchased a new stake in shares of Stereotaxis during the first quarter worth about $58,000. Cherry Creek Investment Advisors Inc. boosted its holdings in shares of Stereotaxis by 33.5% during the second quarter. Cherry Creek Investment Advisors Inc. now owns 32,306 shares of the company’s stock worth $59,000 after purchasing an additional 8,100 shares during the period. Independent Advisor Alliance lifted its holdings in Stereotaxis by 51.4% in the second quarter. Independent Advisor Alliance now owns 89,780 shares of the company’s stock worth $165,000 after buying an additional 30,472 shares during the period. Finally, Renaissance Technologies LLC purchased a new stake in Stereotaxis in the first quarter worth about $269,000. 48.74% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
STXS has been the subject of several research analyst reports. Cowen lowered their price objective on shares of Stereotaxis from $7.00 to $5.00 and set an “outperform” rating for the company in a report on Friday, November 11th. Piper Sandler lowered their price objective on shares of Stereotaxis from $8.00 to $6.00 in a report on Tuesday, August 9th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, Stereotaxis presently has a consensus rating of “Buy” and an average price target of $7.83.
Stereotaxis Stock Down 3.5 %
Stereotaxis Company Profile
Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.
- Get a free copy of the StockNews.com research report on Stereotaxis (STXS)
- Is GameStop Stock Setting Up for Another Short Squeeze?
- Here’s Why SoFi Technologies Stock is Cheap at These Levels
- Warren Buffet Bought Taiwan Semiconductor Stock, Should You?
- MarketBeat: Week in Review 11/14 – 11/18
- Target’s Double Bottom Might Have Just Been Confirmed
Receive News & Ratings for Stereotaxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stereotaxis and related companies with MarketBeat.com's FREE daily email newsletter.